Company intelligence / Profile preview
BHI Therapeutic Sciences
Houston, Delaware, United Statesbluehorizoninternational.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Early clinical results indicate safety and efficacy of their cellular products in improving symptoms across multiple indications. Over 4,000 patients have been treated globally with positive outcomes reported for neurologic recovery and symptom improvement. A Phase I IND trial for acute ischemic stroke using allogeneic cord blood HPCs has been initiated in the US.
- Therapeutic areas
- ImmunologyCardiovascularNeurologyRheumatology
- Modalities
- Autologous stem cellsAllogeneic umbilical cord-derived stem cellsExosomes/extracellular vesicles
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Collaborative relationships with leading institutions/scientists worldwideexclusive licensing from Blue Horizon International AG to operate IP domestically in the US.
Beyond the preview
Go deeper on BHI Therapeutic Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BHI Therapeutic Sciences.